HYPERION DEFI, INC. Cash and Cash Equivalents, Period Increase (Decrease)
HYPERION DEFI, INC. (HYPD) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$5.41 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-14
- HYPERION DEFI, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$5.41M, a 124.22% decline year-over-year.
- HYPERION DEFI, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$1.32M.
- HYPERION DEFI, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$3.52M, a 159.20% decline year-over-year.
- HYPERION DEFI, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$3.04M.
- HYPERION DEFI, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $14.48M, a 677.49% increase from fiscal 2017.
- HYPERION DEFI, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $1.86M, a 108.14% increase from fiscal 2016.
- HYPERION DEFI, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $894.68K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$5.41M 10-Q · filed 2019-05-14 | -$6.73M derived: sum of 2 quarters · filed 2019-05-14 | -$10.25M derived: sum of 3 quarters · filed 2019-05-14 | -$13.29M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | -$4.83M derived: sum of 2 quarters · filed 2019-03-27 | -$7.87M derived: sum of 3 quarters · filed 2019-03-27 | $14.48M 10-K · filed 2019-03-27 |
| 2018-09-30 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$6.56M derived: sum of 2 quarters · filed 2018-11-13 | $15.79M 10-Q · filed 2018-11-13 | $13.64M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-06-30 | -$3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $19.31M 10-Q · filed 2018-08-14 | $17.16M derived: sum of 3 quarters · filed 2019-05-14 | $23.10M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-03-31 | $22.35M 10-Q · filed 2019-05-14 | $20.20M derived: sum of 2 quarters · filed 2019-05-14 | $26.14M derived: sum of 3 quarters · filed 2019-05-14 | $25.10M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $3.79M derived: sum of 2 quarters · filed 2019-03-27 | $2.74M derived: sum of 3 quarters · filed 2019-03-27 | $1.86M 10-K · filed 2019-03-27 |
| 2017-09-30 | $5.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $4.90M derived: sum of 2 quarters · filed 2018-11-13 | $4.02M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.92M 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | -$881.12K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $894.68K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |